Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-04-08 4:31 pm Purchase |
2022-03-31 | 13G | Cytokinetics, Incorporated CYTK |
The Vanguard Group | 8,741,124 10.300% |
1,751,405 (+25.06%) |
Filing History |
| 2022-02-14 09:42 am Sale |
2021-12-31 | 13G | Cytokinetics, Incorporated CYTK |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,327,112 2.770% |
-712,144 (-23.43%) |
Filing History |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Cytokinetics, Incorporated CYTK |
The Vanguard Group | 6,989,719 8.330% |
2,167,729 (+44.96%) |
Filing History |
| 2022-02-09 12:49 pm Sale |
2021-12-31 | 13G | Cytokinetics, Incorporated CYTK |
STATE STREET CORP STT |
3,985,227 4.750% |
-655,696 (-14.13%) |
Filing History |
| 2022-02-09 09:11 am Purchase |
2022-02-08 | 13G | Cytokinetics, Incorporated CYTK |
FMR LLC | 12,589,835 14.999% |
4,101,153 (+48.31%) |
Filing History |
| 2022-01-27 1:59 pm Unchanged |
2021-12-31 | 13G | Cytokinetics, Incorporated CYTK |
BlackRock Inc. BLK |
12,950,964 15.400% |
0 (Unchanged) |
Filing History |
| 2022-01-25 6:45 pm Purchase |
2021-12-31 | 13G | Cytokinetics, Incorporated CYTK |
BlackRock Inc. BLK |
12,950,964 15.400% |
1,339,885 (+11.54%) |
Filing History |
| 2021-07-12 12:07 pm Purchase |
2021-07-09 | 13G | Cytokinetics, Incorporated CYTK |
FMR LLC | 8,488,682 11.832% |
5,864,957 (+223.54%) |
Filing History |
| 2021-02-19 5:02 pm Sale |
2021-02-18 | 13G | Cytokinetics, Incorporated CYTK |
Eastern Capital LTD | 3,062,748 4.300% |
-544,781 (-15.10%) |
Filing History |
| 2021-02-16 3:16 pm Sale |
2020-12-31 | 13G | Cytokinetics, Incorporated CYTK |
Point72 Asset Management, L.P. | 1,176,653 1.700% |
-1,855,196 (-61.19%) |
Filing History |
| 2021-02-10 10:46 am Purchase |
2020-12-31 | 13G | Cytokinetics, Incorporated CYTK |
The Vanguard Group | 4,821,990 6.810% |
276,000 (+6.07%) |
Filing History |
| 2021-02-08 10:07 am Purchase |
2020-12-31 | 13G | Cytokinetics, Incorporated CYTK |
STATE STREET CORP STT |
4,640,923 6.560% |
2,724,961 (+142.22%) |
Filing History |
| 2021-01-25 4:50 pm Purchase |
2020-12-31 | 13G | Cytokinetics, Incorporated CYTK |
BlackRock Inc. BLK |
11,611,079 16.400% |
2,050,477 (+21.45%) |
Filing History |
| 2021-01-13 4:56 pm Sale |
2021-01-11 | 13G | Cytokinetics, Incorporated CYTK |
BIOTECHNOLOGY VALUE FUND L P | 2,728,035 3.900% |
-4,629,984 (-62.92%) |
Filing History |
| 2020-11-16 5:29 pm Purchase |
2020-11-12 | 13G | Cytokinetics, Incorporated CYTK |
BIOTECHNOLOGY VALUE FUND L P | 7,358,019 10.400% |
3,419,739 (+86.83%) |
Filing History |